Health and Healthcare
Short Sellers Take Mixed Stance on Major Pharma
Published:
Last Updated:
The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
Pfizer Inc. (NYSE: PFE) saw its short interest drop to 84.20 million shares from the previous 108.39 million. Shares of Pfizer closed Tuesday at $34.10, within a 52-week trading range of $28.25 to $36.46.
Merck & Co. Inc. (NYSE: MRK) had a slight increase in short interest to 27.87 million shares from 27.68 million in the previous period. Merck shares closed Tuesday at $55.60, in a 52-week range of $45.69 to $61.70.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) short interest increased to 26.20 million shares. The previous level was 24.61 million. The current level is the highest in the past 52 weeks. Shares of Teva closed Tuesday at $51.89, in a 52-week range of $49.51 to $72.31.
Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest decrease to 17.59 million shares from the previous reading of 19.64 million. Shares closed Tuesday at $71.23, within a 52-week range of $51.82 to $73.06.
AbbVie Inc. (NYSE: ABBV) short interest increased to 28.10 million shares, compared to the previous level of 20.99 million. Shares of AbbVie closed Tuesday at $60.70, in a 52-week trading range of $45.45 to $71.60.
Essential Tips for Investing (Sponsored)
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
